INVESTOR LOGIN

LRG BayStar Capital Funds Portfolio

PORTFOLIO COMPANIES

Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:

Curis, Inc. (CRIS)

Curis, Inc. (CRIS)

Curis was formed following a merger of three companies whose combined technological and product development capabilities focus on products in an emerging area of biotechnology known as regenerative medicine.
  http://www.curis.com

Cytogen Corporation (CYTO)

Cytogen Corporation (CYTO)

Cytogen Corporation of Princeton, NJ is a product-driven, oncology-focused biopharmaceutical company. 
http://www.cytogen.com

diaDexus, Inc.

diaDexus, Inc.

A leader in the discovery and validation of novel genomic biomarkers for the detection and treatment of disease, diaDexus' products will enable physicians to detect disease at an earlier stage, predict and monitor response to therapy, and select the most appropriate therapeutic regimen.
 
 
http://www.diadexus.com

Discovery Partners International, Inc.

Discovery Partners International, Inc.

DPI provides unique technologies and services to assist worldwide pharmaceutical and biotechnology companies in the design, development, and production of assays of disease molecules to accelerate their drug discovery activities.
 
 

EntreMed, Inc. (ENMD)

EntreMed, Inc. (ENMD)

EntreMed is a clinical-stage biopharmaceutical company focused on antiangiogenic therapeutics that inhibit abnormal blood vessel growth associated with a broad range of diseases such as cancer, blindness, arthritis and atherosclerosis.
  http://www.entremed.com

 
Arque Capital
This website is for general informational purposes only and is not intended as a solicitation or offering for any investment product or service.
LRG Capital Group, in alliance with Arque Capital, Ltd. Member FINRA/SIPC